KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 136 filers reported holding KYMERA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $190,763 | -25.1% | 6,390,658 | +0.9% | 0.02% | -25.8% |
| Q1 2024 | $254,548 | +87.4% | 6,332,012 | +18.7% | 0.03% | +72.2% |
| Q4 2023 | $135,848 | +93.2% | 5,335,712 | +5.5% | 0.02% | +80.0% |
| Q3 2023 | $70,299 | -38.9% | 5,057,425 | +1.0% | 0.01% | -37.5% |
| Q2 2023 | $115,115 | -16.7% | 5,007,148 | +7.3% | 0.02% | -23.8% |
| Q1 2023 | $138,275 | +26.5% | 4,666,681 | +6.6% | 0.02% | +16.7% |
| Q4 2022 | $109,303 | -99.9% | 4,379,159 | +6.9% | 0.02% | +20.0% |
| Q3 2022 | $89,208,000 | -13.3% | 4,097,712 | -21.6% | 0.02% | +15.4% |
| Q2 2022 | $102,874,000 | -37.6% | 5,224,686 | +34.1% | 0.01% | -23.5% |
| Q1 2022 | $164,845,000 | -26.9% | 3,895,205 | +9.7% | 0.02% | -15.0% |
| Q4 2021 | $225,423,000 | +18.7% | 3,550,528 | +9.8% | 0.02% | +11.1% |
| Q3 2021 | $189,918,000 | +112.2% | 3,233,197 | +75.2% | 0.02% | +125.0% |
| Q2 2021 | $89,479,000 | +146.8% | 1,844,926 | +97.7% | 0.01% | +100.0% |
| Q1 2021 | $36,256,000 | +49.1% | 932,978 | +138.0% | 0.00% | +100.0% |
| Q4 2020 | $24,309,000 | +155.3% | 392,076 | +33.0% | 0.00% | +100.0% |
| Q3 2020 | $9,522,000 | – | 294,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
| Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
| BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
| Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
| Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
| Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
| Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
| AtonRa Partners | 27,125 | $677,040 | 0.86% |
| Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
| EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |